The case highlights ongoing supply chain challenges for popular GLP-1 medicines, like Zepbound, Mounjaro, and Novo Nordisks Wegovy, which have seen unprecedented demand
Microdosing refers to the use of subtherapeutic or lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), with the aim of minimizing side effects while maintaining therapeutic benefits
Coenzyme Q10 (CoQ10) Coenzyme Q10 is a powerful antioxidant that protects the skin from oxidative damage and supports cellular energy production for optimal skin health
Tesamorelins proven human endpoints are visceral fat and hepatic fat in people with HIV
For straightforward sleep optimization without significant anxiety component, DSIP is the more targeted option
Semaglutide is the active ingredient in Wegovy and Ozempic and mimics the GLP-1 hormone